{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:04:19Z","timestamp":1781222659400,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajem.2026.05.031","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:50:35Z","timestamp":1779429035000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early vs delayed opioid administration for pediatric sickle cell vaso-occlusive crisis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"107","author":[{"given":"Ayesha","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Salazar","family":"Ria\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Mohnkern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedanti","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Finch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds S.","family":"Martins Shehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajem.2026.05.031_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ajem.2026.05.031_bb0010","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-067341","article-title":"Trends in sickle cell disease mortality: 1979-2020","volume":"154","author":"Karkoska","year":"2024","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.ajem.2026.05.031_bb0015","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the global burden of disease study 2021","volume":"10","author":"GBD","year":"2023","journal-title":"Lancet Haematol"},{"issue":"10","key":"10.1016\/j.ajem.2026.05.031_bb0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ajem.2026.05.031_bb0025","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jamapediatrics.2025.2967","article-title":"Opioid timeliness in the emergency department and hospitalizations for acute sickle cell pain","volume":"179","author":"Gwarzo","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"9","key":"10.1016\/j.ajem.2026.05.031_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28268","article-title":"The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain","volume":"67","author":"Muslu","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.ajem.2026.05.031_bb0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ajh.26837","article-title":"Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: a multicenter pediatric emergency medicine perspective","volume":"98","author":"Rees","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajem.2026.05.031_bb0040","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025016309","article-title":"Intranasal fentanyl and impact of an emergency department pain protocol for sickle cell disease on hospitalization rates","author":"Martin","year":"2026","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.ajem.2026.05.031_bb0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.2014-2874","article-title":"Timing of opioid administration as a quality indicator for pain crises in sickle cell disease","volume":"135","author":"Mathias","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ajem.2026.05.031_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216414","article-title":"Barriers and facilitators to care for individuals with sickle cell disease in Central North Carolina: the emergency department providers\u2019 perspective","volume":"14","author":"Masese","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajem.2026.05.031_bb0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/asheducation-2017.1.412","article-title":"Improving emergency department-based Care of Sickle Cell Pain","volume":"2017","author":"Glassberg","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ajem.2026.05.031_bb0060","series-title":"Median time to pain medication for patients with a diagnosis of sickle cell disease (SCD) with Vaso-occlusive episode (VOE): Methodology Report","author":"Campbell","year":"2025"},{"key":"10.1016\/j.ajem.2026.05.031_bb0065","series-title":"Difference in median times to pain medication between adult patients with a diagnosis of sickle cell disease (SCD) with Vaso-occlusive episode (VOE) and renal colic: Methodology Report","author":"Campbell","year":"2025"},{"key":"10.1016\/j.ajem.2026.05.031_bb0070","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)[Internet]","author":"Higgins","year":"2023","journal-title":"Cochrane"},{"key":"10.1016\/j.ajem.2026.05.031_bb0075","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ajem.2026.05.031_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"10.1016\/j.ajem.2026.05.031_bb0085","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"10.1016\/j.ajem.2026.05.031_bb0090","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/pbc.24864","article-title":"Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease","volume":"61","author":"Ender","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.ajem.2026.05.031_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26332","article-title":"Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease","volume":"64","author":"Fein","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.ajem.2026.05.031_bb0100","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ajem.2017.11.015","article-title":"Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises","volume":"36","author":"Kelly","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"12","key":"10.1016\/j.ajem.2026.05.031_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23083","article-title":"Clinical and pharmacokinetics overview of intranasal administration of fentanyl","volume":"9","author":"Nakhaee","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.ajem.2026.05.031_bb0110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1213\/ANE.0b013e3182239b8c","article-title":"Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats","volume":"113","author":"Hoekman","year":"2011","journal-title":"Anesth Analg"},{"issue":"195","key":"10.1016\/j.ajem.2026.05.031_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"15","author":"Crowe","year":"2018","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.ajem.2026.05.031_bb0120","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamainternmed.2023.8538","article-title":"Opioid prescribing and outcomes in patients with sickle cell disease post\u20132016 CDC guideline","volume":"184","author":"Kang","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"9757","key":"10.1016\/j.ajem.2026.05.031_bb0125","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajem.2026.05.031_bb0130","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066842","article-title":"Section on Hematology\/Oncology, AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY\/ONCOLOGY. Health supervision for children and adolescents with Sickle Cell Disease: clinical report","volume":"154","author":"Yates","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajem.2026.05.031_bb0135","series-title":"Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014","author":"National Heart L and Blood Institute","year":"2014"},{"key":"10.1016\/j.ajem.2026.05.031_bb0140","doi-asserted-by":"crossref","unstructured":"Piel Fr\u00e9d\u00e9ric B., Steinberg Martin H., Rees David C. Sickle Cell Disease. N Engl J Med [Internet]. [cited 2025 Dec 24];376(16):1561\u201373. Available from https:\/\/doi.org\/10.1056\/NEJMra1510865.","DOI":"10.1056\/NEJMra1510865"},{"issue":"10091","key":"10.1016\/j.ajem.2026.05.031_bb0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet Lond Engl"},{"issue":"22","key":"10.1016\/j.ajem.2026.05.031_bb0150","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1182\/blood-2017-05-782003","article-title":"Targeting novel mechanisms of pain in sickle cell disease","volume":"130","author":"Tran","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ajem.2026.05.031_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40262-012-0016-7","article-title":"Pharmacokinetics of non-intravenous formulations of fentanyl","volume":"52","author":"L\u00f6tsch","year":"2013","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"10.1016\/j.ajem.2026.05.031_bb0160","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jpain.2018.12.003","article-title":"AAAPT diagnostic criteria for acute sickle cell disease pain","volume":"20","author":"Field","year":"2019","journal-title":"J Pain"},{"issue":"1","key":"10.1016\/j.ajem.2026.05.031_bb0165","first-page":"R104","article-title":"Targeting pain at its source in sickle cell disease","volume":"315","author":"Gupta","year":"2018","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"705","key":"10.1016\/j.ajem.2026.05.031_bb0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2019.04.013","article-title":"Sensitization of nociceptors and dorsal horn neurons contributes to pain in sickle cell disease","volume":"13","author":"Uhelski","year":"2019","journal-title":"Neurosci Lett"},{"issue":"10","key":"10.1016\/j.ajem.2026.05.031_bb0175","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1345\/aph.1L168","article-title":"Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery","volume":"42","author":"Foster","year":"2008","journal-title":"Ann Pharmacother"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675726002457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675726002457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:26:19Z","timestamp":1781220379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675726002457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S0735675726002457"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2026.05.031","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early vs delayed opioid administration for pediatric sickle cell vaso-occlusive crisis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2026.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}